• Discreet shipping

    Nobody needs to know but you

  • Board-certified MD

    Prescribed same day for you

  • Made in USA

    By FDA-regulated pharmacies

Discreet shipping

Nobody needs to know but you

Board-certified MD

Prescribed same day for you

Made in USA

By FDA-regulated pharmacies

Why use the Clyne ReNew+ topical solution?

Why use the Clyne ReNew+ topical solution?

Direct-to-scalp care

Delivers growth support exactly where thinning begins.

No pills, no needles

A simple daily dropper feels less invasive than tablets or treatments at a clinic.

Made for women

Addresses thinning with ingredients selected to target female hair loss.

Visual

What to expect with Clyne ReNew+

Month 1 to 2

Some women notice less shedding in daily life as follicles begin to reset. This is the stage where Renew is working quietly to prepare your scalp for new growth.

Month 3 to 5

Early signs of regrowth may appear as soft baby hairs at the crown or part. These strands gradually strengthen, giving the first visible reassurance that progress is happening.

Month 6 and beyond

With continued use, thinning areas can look fuller and existing strands may feel stronger. This is when results are most visible, and many women begin to feel the confidence of seeing healthier hair return.

Why choose Clyne

Noticing more hair in the shower or a thinning hairline? ReGrow+ contains clinically-studied ingredients designed to address hair loss, no pills, and no trips to the doctor's office.
  • Care made for her: A 4-in-1 topical created to support women's hair concerns and address thinning

  • Care that fits your life: Simple to use at home and easy to work into your daily routine.

  • Guided by experts: Reviewed by licensed providers so your plan is safe and tailored to you.

How to get Clyne ReNew+

Select your formula

Now

Fill out your hair profile

Today

Hear from our provider

Within 24 hours

Get your medication

In 4-7 days

FAQs

Hair growth is gradual. In clinical studies of the ingredients in Clyne Renew, some women reported reduced shedding within 2–3 months, with visible regrowth typically appearing after 6 months or longer. Results vary, and consistent use is required.

Some women notice light shedding during the first few weeks. This may be a temporary effect as older hairs fall out and new ones begin to grow.

Clyne Renew is applied directly to the scalp, which limits systemic exposure compared to oral medications. It is not recommended during pregnancy, breastfeeding, or in women with certain medical conditions. A licensed provider will review your health history before prescribing Clyne Renew.

Reported side effects include scalp dryness, redness, or irritation, temporary shedding, mild itching, or skin darkening where applied. Less common effects include persistent irritation or unwanted hair growth where the solution drips. Because spironolactone has hormonal activity, Clyne Renew should not be used during pregnancy, while breastfeeding, or if you have certain cardiovascular conditions. Always consult your provider if side effects persist.

Yes. Clyne Renew contains prescription-strength ingredients such as spironolactone and tretinoin. A licensed healthcare provider will determine if it is right for you.

Yes. You can style or wash your hair as usual once Clyne Renew has dried. Your provider may advise you to avoid layering it with other medicated scalp treatments unless directed.

Clyne Renew does not contain hormones. It includes spironolactone, which reduces the local effect of androgens (such as testosterone and DHT) at the scalp. This action is localized, not systemic.

Hair loss is usually a chronic condition. If treatment with Clyne Renew is stopped, thinning may return. Your provider can guide you on the best long-term approach for your needs.

Clyne Renew should not be used by women who are pregnant, breastfeeding, or planning pregnancy. It should also be avoided if you have uncontrolled high blood pressure, certain cardiovascular conditions, or allergies to its ingredients. Your provider will screen for these risks before prescribing.

If you miss a dose, simply apply Clyne Renew the next day. Missing an occasional dose will not undo progress, but consistency is important for best results.

Yes. You can color or style your hair as usual. Apply Clyne Renew after your scalp is dry and clean. Always follow your stylist’s guidance for scalp care after coloring.

Yes. Many men’s treatments lower DHT throughout the body, which may not be suitable for women who could become pregnant. Clyne Renew is formulated for women, with a topical approach designed to act locally at the scalp.

Minoxidil is a topical ingredient that widens small blood vessels in the scalp. This supports circulation around follicles, which may help some women reduce shedding and support regrowth.

Spironolactone is an anti-androgen. When applied topically in Clyne Renew, it reduces the local effect of hormones that can contribute to follicle miniaturization in women sensitive to DHT.

Tretinoin is a vitamin A derivative. In Clyne Renew, it helps support scalp cell turnover and may improve absorption of other ingredients.

Latanoprost is a prostaglandin analogue originally developed for eye care. In hair use, it helps more follicles remain in the growth phase, which may support thicker, denser strands.

The most common type is female pattern hair loss, also called androgenetic alopecia. It occurs when follicles are sensitive to DHT (dihydrotestosterone), leading to shrinking follicles and thinner strands. Other factors include hormonal changes during perimenopause or after pregnancy, as well as stress, thyroid disease, or nutritional deficiencies.

DHT (dihydrotestosterone) is a hormone made from testosterone in the body. In women sensitive to DHT, it can bind to hair follicles and cause them to shrink, leading to thinner hair. Reducing the effect of DHT helps protect follicles so they can continue producing healthy strands.

Finasteride lowers DHT throughout the body and is approved for men’s hair loss. It is not recommended for women who could become pregnant, as it can cause birth defects. Some clinicians consider off-label use in postmenopausal women, but this requires a medical risk-benefit discussion. Clyne Renew offers a topical, women-specific approach that avoids these systemic risks.

Clyne Renew is a compounded prescription treatment prepared in licensed U.S. pharmacies. Compounded medications are not FDA-approved but are legally permitted and prescribed by licensed healthcare providers when appropriate. Reported effects are based on clinical studies of the individual ingredients (minoxidil, spironolactone, tretinoin, latanoprost). Results vary. Use only under the supervision of a licensed healthcare provider.